Spruce Biosciences earnings were -$37.2M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest SPRB earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$12.3M, down 16.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SPRB reported annual earnings of -$39.0M, with -26.5% growth. The next SPRB earnings date is Aug 13, 2026.
What were Spruce Biosciences's earnings last quarter?
Spruce Biosciences (NASDAQ: SPRB) reported Q1 2026 earnings per share (EPS) of -$8.94, up 62.67% year over year. Total SPRB earnings for the quarter were -$12.27 million. In the same quarter last year, Spruce Biosciences's earnings per share (EPS) was -$23.95.
The next SPRB earnings date is Aug 13, 2026. Add SPRB to your watchlist to be reminded of Spruce Biosciences's next earnings date.
Is Spruce Biosciences profitable or losing money?
As of the last Spruce Biosciences earnings report, Spruce Biosciences is currently losing money. Spruce Biosciences's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$37.19 million, a 32.93% decrease year over year.
What was SPRB's earnings growth in the past year?
As of Spruce Biosciences's earnings date in Q3 2026, Spruce Biosciences's earnings has grown year over year. SPRB earnings in the past year totalled -$37.19 million.
What are Spruce Biosciences's earnings expectations?
The current EPS estimate for Spruce Biosciences's earnings report in Aug 13, 2026 is -$4.79.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.